VCN-01 expanded mPDAC data from VIRAGE Phase 2b trial to be presented at ESMO 2025 -- SYN-004 Interim blinded safety and pharmacokinetic data ...
BridgeBio Oncology Therapeutics, Inc. (“BBOT”) (Nasdaq: BBOT), a clinical-stage biopharmaceutical company focused on ...
The Manila Times on MSN
Stellantis delays new CEO's 2026 strategy presentation
Stellantis has postponed the launch of its latest strategic plan until the second quarter of 2026 to give new CEO Antonio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback